These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19450083)

  • 1. Do tariffs and prices correspond with costs? A case study of orthotic braces.
    Simoens S; Debruyne H; Moldenaers I; Guillaume P; De Coster S; Van den Steen D; Van de Sande S; Ramaekers D; Lona M
    J Med Econ; 2008; 11(2):245-54. PubMed ID: 19450083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation and comparison of ostomy appliance costs with tariffs in Belgium.
    Vanleene V; De Maré L; Moldenaers I; Debruyne H; Simoens S; Van den Steen D; Ramaekers D
    Eur J Health Econ; 2008 Feb; 9(1):17-22. PubMed ID: 17180385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reforming the Belgian market for orthotic braces: what can we learn from the international experience?
    Simoens S; De Coster S; Moldenaers I; Guillaume P; Depoorter A; Van den Steen D; Van de Sande S; Debruyne H; Ramaekers D; Lona M
    Health Policy; 2008 May; 86(2-3):195-203. PubMed ID: 18191275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International comparison of orthotic brace prices.
    Simoens S; Guillaume P; Moldenaers I; Depoorter A; De Coster S; Van den Steen D; Van de Sande S; Debruyne H; Ramaekers D; Lona M
    Eur J Health Econ; 2009 May; 10(2):149-55. PubMed ID: 18521637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ostomy appliance prices in Europe.
    Simoens S; Vanleene V; De Maré L; Moldenaers I; Debruyne H; Van den Steen D; Ramaekers D
    J Med Econ; 2009 Mar; 12(1):17-24. PubMed ID: 19450061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in provider vaccine purchase prices and payer reimbursement.
    Freed GL; Cowan AE; Gregory S; Clark SJ
    Pediatrics; 2009 Dec; 124 Suppl 5():S459-65. PubMed ID: 19948577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the production costs of antiretroviral drugs.
    Pinheiro E; Vasan A; Kim JY; Lee E; Guimier JM; Perriens J
    AIDS; 2006 Aug; 20(13):1745-52. PubMed ID: 16931939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The price of alcohol: a consideration of contextual factors.
    Treno AJ; Gruenewald PJ; Wood DS; Ponicki WR
    Alcohol Clin Exp Res; 2006 Oct; 30(10):1734-42. PubMed ID: 17010140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prices and distribution margins of in-patent drugs in pharmacy: a comparison in seven European countries.
    Garattini L; Motterlini N; Cornago D
    Health Policy; 2008 Mar; 85(3):305-13. PubMed ID: 17928092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in provider vaccine purchase prices and payer reimbursement.
    Freed GL; Cowan AE; Gregory S; Clark SJ
    Pediatrics; 2008 Dec; 122(6):1325-31. PubMed ID: 19047253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Why drug prices are high in sub-Saharan Africa. Analysis of price structure: the case of Senegal].
    Guimier JM; Candau D; Garenne M; Teulières L
    Sante; 2005; 15(1):41-52. PubMed ID: 15919632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital reimbursement price cap for cancer drugs: the French experience in controlling hospital drug expenditures.
    Degrassat-Théas A; Bensadon M; Rieu C; Angalakuditi M; Le Pen C; Paubel P
    Pharmacoeconomics; 2012 Jul; 30(7):565-73. PubMed ID: 22686661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in manufacturer prices of brand name prescription drugs used by older Americans--first quarter 2004 update.
    Gross DJ; Schondelmeyer SW; Raetzman SO
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2004 Jun; (IB69):1-12, 1-2. PubMed ID: 15368653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European prices of newly launched reimbursable pharmaceuticals--a pilot study.
    Martikainen J; Kivi I; Linnosmaa I
    Health Policy; 2005 Nov; 74(3):235-46. PubMed ID: 16226136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and prices of single dental fillings in Europe: a micro-costing study.
    Tan SS; Ken Redekop W; Rutten FF
    Health Econ; 2008 Jan; 17(1 Suppl):S83-93. PubMed ID: 18186032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negotiation advantages of professional associations in health care.
    Barros PP; Martinez-Giralt X
    Int J Health Care Finance Econ; 2005 Jun; 5(2):191-204. PubMed ID: 15912316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Globalization and the price decline of illicit drugs.
    Costa Storti C; De Grauwe P
    Int J Drug Policy; 2009 Jan; 20(1):48-61. PubMed ID: 18272358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the German reference drug program on ex-factory prices of prescription drugs: a panel data approach.
    Augurzky B; Göhlmann S; Gress S; Wasem J
    Health Econ; 2009 Apr; 18(4):421-36. PubMed ID: 18677725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for reimbursement of oncology drugs in Belgium between 2002 and 2013.
    Pauwels K; Huys I; De Nys K; Casteels M; Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(5):859-68. PubMed ID: 25978862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drawing on international experience to reform the Belgian market for ostomy appliances.
    Simoens S; Van den Steen D; Vanleene V; De Maré L; Moldenaers I; Debruyne H; Ramaekers D
    Health Policy; 2007 Feb; 80(2):273-80. PubMed ID: 16647155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.